These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29212503)

  • 1. Synergistic antitumor interaction between valproic acid, capecitabine and radiotherapy in colorectal cancer: critical role of p53.
    Terranova-Barberio M; Pecori B; Roca MS; Imbimbo S; Bruzzese F; Leone A; Muto P; Delrio P; Avallone A; Budillon A; Di Gennaro E
    J Exp Clin Cancer Res; 2017 Dec; 36(1):177. PubMed ID: 29212503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase 1/2 study of valproic acid and short-course radiotherapy plus capecitabine as preoperative treatment in low-moderate risk rectal cancer-V-shoRT-R3 (Valproic acid--short Radiotherapy--rectum 3rd trial).
    Avallone A; Piccirillo MC; Delrio P; Pecori B; Di Gennaro E; Aloj L; Tatangelo F; D'Angelo V; Granata C; Cavalcanti E; Maurea N; Maiolino P; Bianco F; Montano M; Silvestro L; Terranova Barberio M; Roca MS; Di Maio M; Marone P; Botti G; Petrillo A; Daniele G; Lastoria S; Iaffaioli VR; Romano G; Caracò C; Muto P; Gallo C; Perrone F; Budillon A
    BMC Cancer; 2014 Nov; 14():875. PubMed ID: 25421252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HDAC inhibitor, valproic acid, induces p53-dependent radiosensitization of colon cancer cells.
    Chen X; Wong P; Radany E; Wong JY
    Cancer Biother Radiopharm; 2009 Dec; 24(6):689-99. PubMed ID: 20025549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valproic acid potentiates the anticancer activity of capecitabine in vitro and in vivo in breast cancer models via induction of thymidine phosphorylase expression.
    Terranova-Barberio M; Roca MS; Zotti AI; Leone A; Bruzzese F; Vitagliano C; Scogliamiglio G; Russo D; D'Angelo G; Franco R; Budillon A; Di Gennaro E
    Oncotarget; 2016 Feb; 7(7):7715-31. PubMed ID: 26735339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproic acid, an anti-epileptic drug and a histone deacetylase inhibitor, in combination with proteasome inhibitors exerts antiproliferative, pro-apoptotic and chemosensitizing effects in human colorectal cancer cells: underlying molecular mechanisms.
    Abaza MS; Bahman AM; Al-Attiyah RJ
    Int J Mol Med; 2014 Aug; 34(2):513-32. PubMed ID: 24899129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the cyclin-dependent kinase inhibitor P276-00 in human non-small-cell lung cancer cell lines.
    Shirsath N; Rathos M; Chaudhari U; Sivaramakrishnan H; Joshi K
    Lung Cancer; 2013 Nov; 82(2):214-21. PubMed ID: 24051085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Combination of Metformin and Valproic Acid Induces Synergistic Apoptosis in the Presence of p53 and Androgen Signaling in Prostate Cancer.
    Tran LNK; Kichenadasse G; Butler LM; Centenera MM; Morel KL; Ormsby RJ; Michael MZ; Lower KM; Sykes PJ
    Mol Cancer Ther; 2017 Dec; 16(12):2689-2700. PubMed ID: 28802253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproic Acid Induces the Hyperacetylation of P53, Expression of P53 Target Genes, and Markers of the Intrinsic Apoptotic Pathway in Midorganogenesis Murine Limbs.
    Paradis FH; Hales BF
    Birth Defects Res B Dev Reprod Toxicol; 2015 Oct; 104(5):177-83. PubMed ID: 26305274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipopolysaccharide prevents valproic acid-induced apoptosis via activation of nuclear factor-κB and inhibition of p53 activation.
    Tsolmongyn B; Koide N; Odkhuu E; Haque A; Naiki Y; Komatsu T; Yoshida T; Yokochi T
    Cell Immunol; 2013 Apr; 282(2):100-5. PubMed ID: 23770718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone deacetylase inhibitors VPA and TSA induce apoptosis and autophagy in pancreatic cancer cells.
    Gilardini Montani MS; Granato M; Santoni C; Del Porto P; Merendino N; D'Orazi G; Faggioni A; Cirone M
    Cell Oncol (Dordr); 2017 Apr; 40(2):167-180. PubMed ID: 28160167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylase inhibitor valproic acid (VPA) promotes the epithelial mesenchymal transition of colorectal cancer cells via up regulation of Snail.
    Feng J; Cen J; Li J; Zhao R; Zhu C; Wang Z; Xie J; Tang W
    Cell Adh Migr; 2015; 9(6):495-501. PubMed ID: 26632346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiosensitization by the histone deacetylase inhibitor vorinostat under hypoxia and with capecitabine in experimental colorectal carcinoma.
    Saelen MG; Ree AH; Kristian A; Fleten KG; Furre T; Hektoen HH; Flatmark K
    Radiat Oncol; 2012 Sep; 7():165. PubMed ID: 23017053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic induction of p53 mediated apoptosis by valproic acid and nutlin-3 in acute myeloid leukemia.
    McCormack E; Haaland I; Venås G; Forthun RB; Huseby S; Gausdal G; Knappskog S; Micklem DR; Lorens JB; Bruserud O; Gjertsen BT
    Leukemia; 2012 May; 26(5):910-7. PubMed ID: 22064349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long noncoding RNA-ROR promotes the resistance of radiotherapy for human colorectal cancer cells by targeting the p53/miR-145 pathway.
    Yang P; Yang Y; An W; Xu J; Zhang G; Jie J; Zhang Q
    J Gastroenterol Hepatol; 2017 Apr; 32(4):837-845. PubMed ID: 27696511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valproic acid enhances the efficacy of radiation therapy by protecting normal hippocampal neurons and sensitizing malignant glioblastoma cells.
    Thotala D; Karvas RM; Engelbach JA; Garbow JR; Hallahan AN; DeWees TA; Laszlo A; Hallahan DE
    Oncotarget; 2015 Oct; 6(33):35004-22. PubMed ID: 26413814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenomatous polyposis coli determines sensitivity to histone deacetylase inhibitor-induced apoptosis in colon cancer cells.
    Huang X; Guo B
    Cancer Res; 2006 Sep; 66(18):9245-51. PubMed ID: 16982769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gypenosides Synergistically Enhances the Anti-Tumor Effect of 5-Fluorouracil on Colorectal Cancer In Vitro and In Vivo: A Role for Oxidative Stress-Mediated DNA Damage and p53 Activation.
    Kong L; Wang X; Zhang K; Yuan W; Yang Q; Fan J; Wang P; Liu Q
    PLoS One; 2015; 10(9):e0137888. PubMed ID: 26368019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cepharanthine exhibits a potent anticancer activity in p53-mutated colorectal cancer cells through upregulation of p21Waf1/Cip1.
    Rattanawong A; Payon V; Limpanasittikul W; Boonkrai C; Mutirangura A; Wonganan P
    Oncol Rep; 2018 Jan; 39(1):227-238. PubMed ID: 29138869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cells.
    Fedier A; Dedes KJ; Imesch P; Von Bueren AO; Fink D
    Int J Oncol; 2007 Sep; 31(3):633-41. PubMed ID: 17671692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of histone deacetylase inhibitor valproic acid on the anticancer effect of etoposide on neuroblastoma cells.
    Groh T; Hrabeta J; Poljakova J; Eckschlager T; Stiborova M
    Neuro Endocrinol Lett; 2012; 33 Suppl 3():16-24. PubMed ID: 23353839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.